The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
TransAlta Corp
NYSE:TAC
|
CA |
|
Nippon Care Supply Co Ltd
OTC:NYLPF
|
JP |
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
Lindian Resources Ltd
ASX:LIN
|
AU |
|
S
|
SouthGobi Resources Ltd
OTC:SGQRF
|
CA |
|
Solara Active Pharma Sciences Ltd
BSE:541540
|
IN |
|
Thomson Reuters Corp
TSX:TRI
|
CA |
|
W
|
Workday Inc
F:W7D
|
US |
|
Lenovo Group Ltd
HKEX:992
|
CN |
|
CJ Corp
KRX:001040
|
KR |
|
S
|
Singapore Airlines Ltd
SWB:SIA1
|
SG |
|
Tabcorp Holdings Ltd
ASX:TAH
|
AU |
|
AC Immune SA
F:IMR
|
CH |
|
L
|
LNA Sante SA
LSE:0OR2
|
FR |
|
E
|
EverProX Technologies Co Ltd
SZSE:300548
|
CN |
|
BRP Inc
TSX:DOO
|
CA |
|
P
|
Prosegur Compania de Seguridad SA
SWB:PRHA
|
ES |
|
S
|
Solstad Maritime ASA
OSE:SOMA
|
NO |
|
M
|
McDonald's Holdings Company Japan Ltd
XMUN:MJ8
|
JP |
|
S
|
Suntrust Resort Holdings Inc
XPHS:SUN
|
PH |
|
Orkla ASA
F:OKL0
|
NO |
|
F
|
Frontier Lithium Inc
SWB:HL2
|
CA |
|
B
|
Babcock International Group PLC
DUS:BW3
|
UK |
|
E
|
Expedia Group Inc
F:E3X1
|
US |
TransAlta Corp (TAC)’s 12-month stock price forecast through November 2027 has a consensus target of $17.54, implying 36% upside. The forecast is based on price targets from 11 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
TAC is 17.54 USD with a low forecast of 10.13 USD and a high forecast of 21.06 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been 1%. The projected CAGR for the next 3 years is 5%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 0%. The projected CAGR for the next 3 years is -2%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 0%. The projected CAGR for the next 3 years is 87%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more